PTGX PROTAGONIST THERAPEUTICS INC More: the full row for PROTAGONIST THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,449,183 shares; 2025Q1: 2,449,183 shares; 2025Q2: 2,449,183 shares; 2025Q3: 2,449,183 shares; 2025Q4: 2,449,183 shares; 2026Q1: 2,449,183 shares; 2026Q2: 2,449,183 shares; 2026Q3: 2,449,183 shares 2,449,183 $345M 45.3% 0 Timeline NBTX NANOBIOTIX More: the full row for NANOBIOTIX Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,623,816 shares; 2025Q1: 5,623,816 shares; 2025Q2: 5,623,816 shares; 2025Q3: 5,623,816 shares; 2025Q4: 5,623,816 shares; 2026Q1: 5,623,816 shares; 2026Q2: 5,623,816 shares; 2026Q3: 5,623,816 shares 5,623,816 $175M 23.01% 0 Timeline MGTX MEIRAGTX HLDGS PLC More: the full row for MEIRAGTX HLDGS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,641,064 shares; 2025Q1: 6,641,064 shares; 2025Q2: 6,641,064 shares; 2025Q3: 6,641,064 shares; 2025Q4: 6,641,064 shares; 2026Q1: 6,641,064 shares; 2026Q2: 6,641,064 shares; 2026Q3: 6,641,064 shares 6,641,064 $73.1M 9.59% 0 Timeline RAPP RAPPORT THERAPEUTICS INC More: the full row for RAPPORT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,498,051 shares; 2025Q1: 2,498,051 shares; 2025Q2: 2,498,051 shares; 2025Q3: 1,784,517 shares; 2025Q4: 1,784,517 shares; 2026Q1: 1,784,517 shares; 2026Q2: 1,784,517 shares; 2026Q3: 1,784,517 shares 1,784,517 $60M 7.87% 0 Timeline CTNM CONTINEUM THERAPEUTICS INC More: the full row for CONTINEUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,979,173 shares; 2025Q1: 1,979,173 shares; 2025Q2: 1,979,173 shares; 2025Q3: 1,979,173 shares; 2025Q4: 1,979,173 shares; 2026Q1: 1,979,173 shares; 2026Q2: 1,979,173 shares; 2026Q3: 1,979,173 shares 1,979,173 $26.6M 3.49% 0 2026-11-03, 13G/A : 1,979,173 shares, 5.6% of the class, 13G/A filed 2026-11-06 Timeline CBRS CEREBRAS SYSTEMS INC More: the full row for CEREBRAS SYSTEMS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 53,586 shares; 2026Q3: 128,649 shares 128,649 $22.9M 3% +75,063 Timeline XNCR XENCOR INC More: the full row for XENCOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 748,062 shares; 2025Q1: 748,062 shares; 2025Q2: 748,062 shares; 2025Q3: 748,062 shares; 2025Q4: 748,062 shares; 2026Q1: 748,062 shares; 2026Q2: 748,062 shares; 2026Q3: 748,062 shares 748,062 $18.7M 2.45% 0 Timeline LEGN LEGEND BIOTECH CORP More: the full row for LEGEND BIOTECH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 814,586 shares; 2025Q1: 814,586 shares; 2025Q2: 814,586 shares; 2025Q3: 814,586 shares; 2025Q4: 814,586 shares; 2026Q1: 814,586 shares; 2026Q2: 814,586 shares; 2026Q3: 814,586 shares 814,586 $16.2M 2.13% 0 Timeline FATE FATE THERAPEUTICS INC More: the full row for FATE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,379,064 shares; 2025Q1: 3,379,064 shares; 2025Q2: 3,379,064 shares; 2025Q3: 3,379,064 shares; 2025Q4: 3,379,064 shares; 2026Q1: 3,379,064 shares; 2026Q2: 3,379,064 shares; 2026Q3: 3,379,064 shares 3,379,064 $8.01M 1.05% 0 Timeline CVRX CVRX INC More: the full row for CVRX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,103,430 shares; 2025Q1: 4,103,430 shares; 2025Q2: 4,103,430 shares; 2025Q3: 4,103,430 shares; 2025Q4: 4,024,861 shares; 2026Q1: 4,024,861 shares; 2026Q2: 4,024,861 shares; 2026Q3: 4,024,861 shares 4,024,861 $7.04M 0.92% 0 Timeline PRCT PROCEPT BIOROBOTICS CORP More: the full row for PROCEPT BIOROBOTICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 357,939 shares; 2025Q1: 357,939 shares; 2025Q2: 357,939 shares; 2025Q3: 357,939 shares; 2025Q4: 357,939 shares; 2026Q1: 357,939 shares; 2026Q2: 357,939 shares; 2026Q3: 357,939 shares 357,939 $6.52M 0.86% 0 Timeline NMRA NEUMORA THERAPEUTICS INC. More: the full row for NEUMORA THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,849,445 shares; 2025Q1: 1,849,445 shares; 2025Q2: 1,849,445 shares; 2025Q3: 1,849,445 shares; 2025Q4: 1,849,445 shares; 2026Q1: 1,849,445 shares; 2026Q2: 1,849,445 shares; 2026Q3: 1,849,445 shares 1,849,445 $1.1M 0.14% 0 Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 53,732 shares; 2026Q1: 53,732 shares; 2026Q2: 53,732 shares; 2026Q3: 53,732 shares 53,732 $1.03M 0.13% 0 Timeline LAB STANDARD BIOTOOLS INC More: the full row for STANDARD BIOTOOLS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 311,967 shares; 2025Q1: 311,967 shares; 2025Q2: 311,967 shares; 2025Q3: 311,967 shares; 2025Q4: 311,967 shares; 2026Q1: 311,967 shares; 2026Q2: 311,967 shares; 2026Q3: 311,967 shares 311,967 $231K 0.03% 0 Timeline ACET ADICET BIO INC More: the full row for ADICET BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 22,779 shares; 2026Q1: 22,779 shares; 2026Q2: 22,779 shares; 2026Q3: 22,779 shares 22,779 $163K 0.02% 0 Timeline